Guidelines for the diagnosis and management of adult aplastic anaemia

Sally B. Killick (Writing Group Chair), Nick Bown, Jamie Cavenagh, Inderjeet Dokal, Theodora Foukaneli, Peter Hillmen, Robin Ireland, Austin Kulasekararaj, Ghulam Mufti, John A Snowden, Sujith Samarasinghe, Anna Wood (BCSH Task Force Member), Judith C.W. Marsh on behalf of the British Society for Standards in Haematology. The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust, Bournemouth, Northern Genetics Service, Newcastle upon Tyne, St Bartholomew’s Hospital, Barts Health NHS Trust, London, Barts and The London School of Medicine and Dentistry, Queen Mary University of London and Barts Health NHS Trust, London, Addenbrooks Hospital, University of Cambridge, Cambridge, Leeds Teaching Hospitals, Leeds, Kings College Hospital NHS Foundation Trust, London, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield Great Ormond Street Hospital for Children NHS Foundation Trust, London, West Hertfordshire NHS Trust, Watford.

[1]  B. Camitta.  Pathogenesis and treatment of aplastic anemia. , 1984, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[2]  Xingmin Feng,et al.  Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia. , 2006, Blood.

[3]  J. Maciejewski,et al.  Clonal evolution in aplastic anemia. , 2011, Hematology. American Society of Hematology. Education Program.

[4]  B. Alter,et al.  Pathophysiology and management of inherited bone marrow failure syndromes. , 2010, Blood reviews.

[5]  E. Guinan,et al.  An update on the management of severe idiopathic aplastic anaemia in children , 2007, British journal of haematology.

[6]  T. Necheles,et al.  Oxymetholone therapy in aplastic anemia. , 1968, Blood.

[7]  S. Knowles,et al.  Pilot study of HLA alloimmunization after transfusion with pre‐storage leucodepleted blood products in aplastic anaemia , 1997, British journal of haematology.

[8]  Sunil V. Rao,et al.  Red Blood Cell Transfusion: A Clinical Practice Guideline From the AABB* , 2012, Annals of Internal Medicine.

[9]  J. Bennett,et al.  Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach , 2009, Haematologica.

[10]  A. Bacigalupo.  How I treat acquired aplastic anemia. , 2017, Blood.

[11]  S. Hopewell,et al.  Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation. , 2012, The Cochrane database of systematic reviews.

[12]  D. Nathan,et al.  Selection of patients for bone marrow transplantation in severe aplastic anemia. , 1975, Blood.

[13]  D. Follmann,et al.  Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. , 2003, JAMA.

[14]  Frank Saran,et al.  Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force , 2011, British journal of haematology.

[15]  J. Passweg,et al.  Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party. , 1999, Blood.

[16]  N. Young,et al.  Decreased infection-related mortality and improved survival in severe aplastic anemia in the past two decades. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  J. Rommens,et al.  Draft consensus guidelines for diagnosis and treatment of Shwachman‐Diamond syndrome , 2011, Annals of the New York Academy of Sciences.

[18]  N. Young,et al.  Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia , 2009, British journal of haematology.

[19]  M. Aljurf,et al.  Current Outcome Of HLA Identical Sibling Vs Unrelated DONOR Transplants In Severe Aplastic Anemia : An EBMT Analysis , 2013 .

[20]  A. Buser,et al.  Comment to “Favorable outcome of patients who have 13q deletion: a suggestion for revision of the WHO ‘MDS-U’ designation” Haematologica. 2012;97(12):1845-9. , 2013, Haematologica.

[21]  Neal Young,et al.  Diagnosis and management of paroxysmal nocturnal hemoglobinuria. , 2005, Blood.

[22]  J. Čermák,et al.  Efficacy And Safety Of Administration Of Oral Iron Chelator Deferiprone In Patients With Early Myelodysplastic Syndrome , 2011, Hemoglobin.

[23]  N. Young,et al.  Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia. , 2012, Blood.

[24]  Renhao Li,et al.  Specific Inhibition Of Ectodomain Shedding Of GPIba By Targeting Its Shedding Cleavage Site , 2013 .

[25]  R. Champlin,et al.  Donor selection in T cell-replete haploidentical hematopoietic stem cell transplantation: knowns, unknowns, and controversies. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[26]  N. Young,et al.  Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia. , 2002, Blood.

[27]  E. Gordon-Smith,et al.  Pregnancy associated aplastic anaemia: a report of five cases and review of current management , 1989, British journal of haematology.

[28]  V. Cemerikić,et al.  Hypocellular myelodysplastic syndromes , 2005, Medical oncology.

[29]  P. Vyas,et al.  Guidelines for the diagnosis and management of adult myelodysplastic syndromes , 2014, British journal of haematology.

[30]  R. Nuscher,et al.  Bone marrow transplantation. , 1977, The American journal of nursing.

[31]  S. Eustace,et al.  Bone marrow. , 2010, Magnetic resonance imaging clinics of North America.

[32]  A. Tichelli,et al.  Diagnosis of acquired aplastic anemia , 2013, Bone Marrow Transplantation.

[33]  M. Aljurf,et al.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation , 2012, Bone Marrow Transplantation.

[34]  A. Ganser,et al.  Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trial. , 2010, Blood.

[35]  H. Deeg,et al.  Gamma-irradiation of pretransplant blood transfusions from unrelated donors prevents sensitization to minor histocompatibility antigens on dog leukocyte antigen-identical canine marrow grafts. , 1994, Transplantation.

[36]  J. Passweg,et al.  Outcome of Pregnancy and Disease Course among Women with Aplastic Anemia Treated with Immunosuppression , 2002, Annals of Internal Medicine.

[37]  Mini P. Singh,et al.  Human parvovirus B19 in patients with aplastic anemia , 2005, American journal of hematology.

[38]  J. Orange,et al.  GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. , 2014, Blood.

[39]  H. Deeg,et al.  Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia. , 2011, Blood.

[40]  B. Dumitriu,et al.  Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug. , 2014, Blood.

[41]  E. Gluckman,et al.  Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT * SAA Working Party , 1988, British journal of haematology.

[42]  N. Young,et al.  Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. , 2011, The New England journal of medicine.

[43]  M. Horwitz.  GATA2 deficiency: flesh and blood. , 2014, Blood.

[44]  C. Hendry,et al.  Relapse of severe aplastic anaemia after influenza immunization , 2002, British journal of haematology.

[45]  N. Russell,et al.  Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation , 2014, Bone Marrow Transplantation.

[46]  C. M. Cadwell,et al.  Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model. , 2009, Blood.

[47]  R. Kashyap,et al.  Pregnancy associated aplastic anemia: Maternal and fetal outcome , 2003, The journal of obstetrics and gynaecology research.

[48]  D. McKay,et al.  Pregnancy in recipients of solid organs--effects on mother and child. , 2006, The New England journal of medicine.

[49]  G. Mufti,et al.  Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome. , 2014, Blood.

[50]  S Dilly,et al.  Bone marrow pathology , 1949 .

[51]  J. Moreau,et al.  Severe pancytopenia triggered by recombinant hepatitis B vaccine , 2000, British journal of haematology.

[52]  J. Stockman.  A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation , 2013 .

[53]  B. Camitta.  What Is the Definition of Cure for Aplastic Anemia? , 2000, Acta Haematologica.

[54]  M. Bessler,et al.  Recent insights into inherited bone marrow failure syndromes , 2012, Current opinion in pediatrics.

[55]  G. Ehninger,et al.  Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem-cell transplantation. , 2007, Blood.

[56]  D. Gómez-Almaguer,et al.  Danazol as first-line therapy for aplastic anemia , 2011, Annals of Hematology.

[57]  J. Passweg,et al.  Aplastic anemia: first-line treatment by immunosuppression and sibling marrow transplantation. , 2010, Hematology. American Society of Hematology. Education Program.

[58]  B. Dumitriu,et al.  Bone marrow failure and the telomeropathies. , 2014, Blood.

[59]  B. Dumitriu,et al.  Moderate-dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution. , 2014, Blood.

[60]  N. Geller,et al.  High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial , 2000, The Lancet.

[61]  S. Kim,et al.  Supportive management of pregnancy‐associated aplastic anemia , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[62]  M. Aljurf,et al.  Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups , 2012, Haematologica.

[63]  賢二 鈴木.  慢性副鼻腔炎に対するrandomized controlled study , 2002 .

[64]  S. Jane,et al.  Immune‐mediated cytopenias in human immunodeficiency virus: the first reported case of idiopathic aplastic anaemia successfully treated with immunosuppression , 2013, Internal medicine journal.

[65]  G. Mufti,et al.  Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemia. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[66]  G. Mufti,et al.  Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party. , 2012, Blood.

[67]  N. Young,et al.  Paroxysmal Nocturnal Hemoglobinuria Cells in Patients with Bone Marrow Failure Syndromes , 1999, Annals of Internal Medicine.

[68]  S. Samarasinghe,et al.  How I manage aplastic anaemia in children , 2012, British journal of haematology.

[69]  G. Mufti,et al.  Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia. , 2011, Blood.

[70]  N. Young,et al.  Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party , 2010, British journal of haematology.

[71]  N. Young,et al.  Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia. , 2010, JAMA.

[72]  Jonathan P. Kerr,et al.  Guidelines for the use of platelet transfusions , 2017, British journal of haematology.

[73]  J. Cavenagh,et al.  Guidelines for the diagnosis and management of aplastic anaemia , 2009, British journal of haematology.

[74]  Guidelines for the use of platelet transfusions , 2003, British journal of haematology.

[75]  A. Ganser,et al.  Syngeneic transplantation in aplastic anemia: pre-transplant conditioning and peripheral blood are associated with improved engraftment: an observational study on behalf of the Severe Aplastic Anemia and Pediatric Diseases Working Parties of the European Group for Blood and Marrow Transplantation , 2013, Haematologica.

[76]  A. Bacigalupo,et al.  Front-line immunosuppressive treatment of acquired aplastic anemia , 2013, Bone Marrow Transplantation.

[77]  E. Wood,et al.  A no-prophylaxis platelet-transfusion strategy for hematologic cancers. , 2013, The New England journal of medicine.

[78]  X. Vidal,et al.  Epidemiology of aplastic anemia: a prospective multicenter study , 2008, Haematologica.

[79]  A. Gratwohl,et al.  Effectiveness of Immunosuppressive Therapy in Older Patients with Aplastic Anemia , 1999, Annals of Internal Medicine.

[80]  J. Tooze,et al.  Clinical relevance of cytogenetic abnormalities at diagnosis of acquired aplastic anaemia in adults , 2006, British journal of haematology.

[81]  A. Ganser,et al.  Hematopoietic growth factors in the treatment of acquired bone marrow failure states. , 2007, Seminars in hematology.

[82]  P. Ljungman,et al.  Supportive care in severe and very severe aplastic anemia , 2013, Bone Marrow Transplantation.

[83]  M. Ballmaier,et al.  Congenital Amegakaryocytic Thrombocytopenia: Clinical Presentation, Diagnosis, and Treatment , 2011, Seminars in thrombosis and hemostasis.

[84]  E. Lanino,et al.  Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working party , 2010, Haematologica.

[85]  S. Lewis,et al.  British Committee for Standards in Haematology , 1969 .

[86]  R. Storb,et al.  Hepatitis-associated aplastic anemia. , 1997, The New England journal of medicine.

[87]  M. Sagmeister,et al.  A restrictive platelet transfusion policy allowing long-term support of outpatients with severe aplastic anemia. , 1999, Blood.

[88]  C. O'keefe,et al.  SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes. , 2011, Blood.

[89]  D. Blaise,et al.  Allogeneic stem cell transplantation in paroxysmal nocturnal hemoglobinuria , 2012, Haematologica.

[90]  F. Craig,et al.  Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry , 2010, Cytometry. Part B, Clinical cytometry.

[91]  B. Alter.  Diagnosis, genetics, and management of inherited bone marrow failure syndromes. , 2007, Hematology. American Society of Hematology. Education Program.

[92]  S. Staszewski,et al.  First case of successful allogeneic stem cell transplantation in an HIV-patient who acquired severe aplastic anemia. , 2007, Haematologica.

[93]  邓伟平,et al.  Dyskeratosis congenita , 2007 .

[94]  P. Veys,et al.  Excellent outcome of matched unrelated donor transplantation in paediatric aplastic anaemia following failure with immunosuppressive therapy: a United Kingdom multicentre retrospective experience , 2012, British journal of haematology.

[95]  A. Kulasekararaj,et al.  Management of the refractory aplastic anemia patient: what are the options? , 2013, Hematology. American Society of Hematology. Education Program.

[96]  N. Young,et al.  Granulocyte transfusions in severe aplastic anemia: an eleven-year experience , 2009, Haematologica.

[97]  E. Thiel,et al.  A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation. , 2011, Blood.